These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 14036943)

  • 1. The c ytological effect of carzinostatin on experimental tumor.
    KUMAGI K; MIUAZAKI K; RIKIMARU M; ISHIDA N
    J Antibiot (Tokyo); 1962 May; 15():154. PubMed ID: 14036943
    [No Abstract]   [Full Text] [Related]  

  • 2. [Biological and pharmacological studies on Tuberactin, a new antibiotic].
    Nagata A; Hayano K; Hoshino Y
    Kekkaku; 1968 Jul; 43(7):249-53. PubMed ID: 4302508
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro activity of C-8-methoxy fluoroquinolones against mycobacteria when combined with anti-tuberculosis agents.
    Lu T; Drlica K
    J Antimicrob Chemother; 2003 Dec; 52(6):1025-8. PubMed ID: 14613961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Resistance to antituberculosis drug in France; data provided by the Azay-Mycobacteria network and the National Reference Center on Mycobacteria].
    Robert J; Veziris N;
    Med Mal Infect; 2008 Jun; 38 Suppl 2():S68-70. PubMed ID: 18598875
    [No Abstract]   [Full Text] [Related]  

  • 5. Facile synthesis of active antitubercular, cytotoxic and antibacterial agents: a Michael addition approach.
    Chande MS; Verma RS; Barve PA; Khanwelkar RR; Vaidya RB; Ajaikumar KB
    Eur J Med Chem; 2005 Nov; 40(11):1143-8. PubMed ID: 16040160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-tubercular agents. Part IV: Synthesis and antimycobacterial evaluation of nitroheterocyclic-based 1,2,4-benzothiadiazines.
    Kamal A; Ahmed SK; Reddy KS; Khan MN; Shetty RV; Siddhardha B; Murthy US; Khan IA; Kumar M; Sharma S; Ram AB
    Bioorg Med Chem Lett; 2007 Oct; 17(19):5419-22. PubMed ID: 17692520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drugs and exocrine pancreatic function in man.
    Fleischer K
    Acta Hepatogastroenterol (Stuttg); 1978 Apr; 25(2):162-5. PubMed ID: 349996
    [No Abstract]   [Full Text] [Related]  

  • 8. [Bactericidal therapy in patients with tuberculosis].
    Krasnov VA; Ursov IG
    Probl Tuberk Bolezn Legk; 2004; (3):21-6. PubMed ID: 15338895
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthesis and evaluation of in vitro anti-microbial and anti-tubercular activity of 2-styryl benzimidazoles.
    Shingalapur RV; Hosamani KM; Keri RS
    Eur J Med Chem; 2009 Oct; 44(10):4244-8. PubMed ID: 19540630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, antibacterial and antitubercular activities of some 7-[4-(5-amino-[1,3,4]thiadiazole-2-sulfonyl)-piperazin-1-yl] fluoroquinolonic derivatives.
    Talath S; Gadad AK
    Eur J Med Chem; 2006 Aug; 41(8):918-24. PubMed ID: 16781799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of new 4-pyrrol-1-yl benzoic acid hydrazide analogs and some derived oxadiazole, triazole and pyrrole ring systems: a novel class of potential antibacterial and antitubercular agents.
    Joshi SD; Vagdevi HM; Vaidya VP; Gadaginamath GS
    Eur J Med Chem; 2008 Sep; 43(9):1989-96. PubMed ID: 18207286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Alternative schemes of eradication therapy and ways of overcoming acquired resistance of Helicobacter pylori to the treatment].
    Tsimmerman IaS
    Klin Med (Mosk); 2004; 82(2):9-15. PubMed ID: 15106503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of isonicotinoylhydrazones from anacardic acid and their in vitro activity against Mycobacterium smegmatis.
    Swamy BN; Suma TK; Rao GV; Reddy GC
    Eur J Med Chem; 2007 Mar; 42(3):420-4. PubMed ID: 17112641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antimycobacterial evaluation of certain fluoroquinolone derivatives.
    Zhao YL; Chen YL; Sheu JY; Chen IL; Wang TC; Tzeng CC
    Bioorg Med Chem; 2005 Jun; 13(12):3921-6. PubMed ID: 15911308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycobacterium mucogenicum group infections: a review.
    Adékambi T
    Clin Microbiol Infect; 2009 Oct; 15(10):911-8. PubMed ID: 19845703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The thuggacins, novel antibacterial macrolides from Sorangium cellulosum acting against selected Gram-positive bacteria.
    Irschik H; Reichenbach H; Höfle G; Jansen R
    J Antibiot (Tokyo); 2007 Dec; 60(12):733-8. PubMed ID: 18276996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of in vitro synergy when three antimicrobial agents are combined against Mycobacterium tuberculosis.
    Bhusal Y; Shiohira CM; Yamane N
    Int J Antimicrob Agents; 2005 Oct; 26(4):292-7. PubMed ID: 16150578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Counterfeit or substandard antimicrobial drugs: a review of the scientific evidence.
    Kelesidis T; Kelesidis I; Rafailidis PI; Falagas ME
    J Antimicrob Chemother; 2007 Aug; 60(2):214-36. PubMed ID: 17550892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Condensation of antitubercular hydrazides with ketones containing the furan nucleus].
    MUSANTE C; STENER A
    Farmaco Sci; 1960 Apr; 15():221-7. PubMed ID: 13854051
    [No Abstract]   [Full Text] [Related]  

  • 20. A facile synthesis, antibacterial, and antitubercular studies of some piperidin-4-one and tetrahydropyridine derivatives.
    Aridoss G; Amirthaganesan S; Kumar NA; Kim JT; Lim KT; Kabilan S; Jeong YT
    Bioorg Med Chem Lett; 2008 Dec; 18(24):6542-8. PubMed ID: 18952418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.